Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Medical treatment involving investigational drugs and genetic profile of thymic carcinoma.

Lung cancer (Amsterdam, Netherlands) - 1 Mar 2016

Asao Tetsuhiko, Fujiwara Yutaka, Sunami Kuniko, Kitahara Shinsuke, Goto Yasushi, Kanda Shintaro, Horinouchi Hidehito, Nokihara Hiroshi, Yamamoto Noboru, Ichikawa Hitoshi, Kohno Takashi, Tsuta Koji, Watanabe Shun-ichi, Takahashi Kazuhisa, Ohe Yuichiro

Abstract excerpt

BACKGROUND: Thymic carcinoma is a rare neoplasm of the thymus, and information regarding its genetic profile and optimal medical treatment is limited. We sought to characterize the genetic profile of thymic carcinoma and to evaluate the efficacy of various medical treatments, including treatment with tyrosine kinase inhibitors (TKIs), cytotoxic agents, and immune checkpoint inhibitors. METHODS: We retrospectively...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Combined Modality Therapy

Share to Drugs, Investigational

Share to Kaplan-Meier Estimate

Share to Neoplasm Staging

Share to Thymus Neoplasms

Share to Treatment Outcome

Source

Identifiers

PMID: 26898618
DOI: 10.1016/j.lungcan.2016.01.004

Genes

KIT
KRAS
NRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Medical treatment involving investigational drugs and genetic profile of thymic carcinoma.PMID 26898618Read ↗

Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways.Semantic proximity Read ↗

Comprehensive Genomic Profiling of 274 Thymic Epithelial Tumors Unveils Oncogenic Pathways and Predictive Biomarkers.Semantic proximity Read ↗

Mutation Profile of Thymic Carcinoma and Thymic Neuroendocrine Tumor by Targeted Next-generation Sequencing.Semantic proximity Read ↗

Integrated Molecular and Clinical Analysis of Thymic Epithelial Tumors.Semantic proximity Read ↗

Genomic characterization of thymic epithelial tumors in a real-world datasetSemantic proximity Read ↗

Identification of novel mutations of TP53, ALK and RET gene in metastatic thymic squamous cell carcinoma and its therapeutic implication.Semantic proximity Read ↗

The Molecular Landscape of Thymic Epithelial Tumors: A Comprehensive ReviewSemantic proximity Read ↗

Genetic profiling of thymic carcinoma using targeted next-generation sequencing.Semantic proximity Read ↗

Mutations of epigenetic regulatory genes are common in thymic carcinomas.Semantic proximity Read ↗

Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.Semantic proximity Read ↗

Molecular landscape of thymic epithelial tumors.Semantic proximity Read ↗

Somatic and germline genomic variation in thymic carcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.